Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yves Bécouarn"'
Autor:
Serge Evrard, Grégoire Desolneux, Carine Bellera, Thomas Esnaud, Yves Bécouarn, Denis Collet, Najim Chafai, Francois Marchal, Laurent Cany, Emilie Lermite, Michel Rivoire, Simone Mathoulin-Pélissier
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
Abstract Objective The primary objective of this non-randomised phase II study was to evaluate the combination of systemic chemotherapy plus cetuximab after complete cytoreductive surgery (CCS) for treatment of isolated colorectal peritoneal carcinom
Externí odkaz:
https://doaj.org/article/2732079035954b72b4ceee07ea39cc31
Autor:
Marie Desjardin, Benjamin Bonhomme, Brigitte Le Bail, Serge Evrard, Véronique Brouste, Gregoire Desolneux, Marianne Fonck, Yves Bécouarn, Dominique Béchade
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Background: Pre-operative chemotherapy for colorectal liver metastasis (CRLM) is thought to be the cause of hepatotoxicity of non-tumoural parenchyma. Studies on hepatotoxicity are contradictory. We investigated the impact of a single-line pre-operat
Externí odkaz:
https://doaj.org/article/2ae3466dcf7d4f3ca4c19bcc3dfd734e
Autor:
Dominique Béchade, Marie Desjardin, Emma Salmon, Grégoire Désolneux, Yves Bécouarn, Serge Evrard, Marianne Fonck
Publikováno v:
Case Reports in Gastroenterology, Vol 10, Iss 1, Pp 174-180 (2016)
Pancreatic acinar cell carcinoma (ACC) is a rare malignant neoplasm that accounts for 1–2% of all pancreatic neoplasms. Here we report two cases of ACC and describe their clinical features, the therapies used to treat them, and their prognosis. The
Externí odkaz:
https://doaj.org/article/ebd922a8472d458f9a9ee5abd84e9aae
Autor:
Grégoire Désolneux, Camille Mazière, Jérémy Vara, Véronique Brouste, Marianne Fonck, Dominique Béchade, Yves Bécouarn, Serge Evrard
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0122816 (2015)
BackgroundCytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) has long been considered the standard treatment for colorectal peritoneal metastases (CPM). However, although efficacy of surgery has been d
Externí odkaz:
https://doaj.org/article/791cc6a15db94877a75bd822719c0683
Autor:
Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez-Nebout, Véronique Vendrely, Xavier Artignan, Olivier Bouché, Dany Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Najib Lamfichekh, Béata Juzyna, Claire Jouffroy-Zeller, Eric Rullier, Frédéric Marchal, Sophie Gourgou, Florence Castan, Christophe Borg, Philippe Ronchin, Jean-François Seitz, Stéphane Corbinais, Emmanuel Maillard, Monique Noirclerc, Farid El Hajbi, Anne-Laure Villing, Yves Bécouarn, Lam Foong Fat Lam Kam Sang, Pascal Artru, Jean-Baptiste Bachet, Fayçal Hocine, Catherine Ligeza-Poisson, Claire Vautravers, Meher Ben Abdelghani, Thomas Aparicio, Elise Desot, Isabelle Marquis
Publikováno v:
The Lancet Oncology. 22:702-715
Summary Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery, and adjuvant chemotherapy controls local disease, but distant metastases remain common. We aimed to assess whether administering neoadjuvant chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbf10530c95450b1ac17465cd9fe2ad
https://doi.org/10.1016/s1470-2045(21)00079-6
https://doi.org/10.1016/s1470-2045(21)00079-6
Autor:
Yves Bécouarn, Marie Desjardin, Dominique Béchade, Benjamin Bonhomme, Brigitte Le Bail, Serge Evrard, Marianne Fonck, Gregoire Desolneux, Véronique Brouste
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Background: Pre-operative chemotherapy for colorectal liver metastasis (CRLM) is thought to be the cause of hepatotoxicity of non-tumoural parenchyma. Studies on hepatotoxicity are contradictory. We investigated the impact of a single-line pre-operat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa20f576ff8844bf36719156eb19edf
https://doaj.org/article/2ae3466dcf7d4f3ca4c19bcc3dfd734e
https://doaj.org/article/2ae3466dcf7d4f3ca4c19bcc3dfd734e
Publikováno v:
Bulletin du cancer. 105(3)
Tyrosine kinase inhibitors (TKIs) are used for the targeted treatment of solid cancers. TKIs produce a variable incidence of liver adverse events (5-25%) which can progress to severe liver injury in a minority of patients if treatment is maintained d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce34c32c9d9687c300d36f2d0d1cb1e0
https://pubmed.ncbi.nlm.nih.gov/29471963
https://pubmed.ncbi.nlm.nih.gov/29471963
Autor:
Jean Francois Delattre, Romain Cohen, Julie Henriques, Antoine Falcoz, Jean-François Emile, Serge Fratte, Benoist Chibaudel, Jérôme Dauba, Olivier Jean Marie Dupuis, Yves Bécouarn, Frédéric Bibeau, Julien Taieb, Thierry Andre, Dewi Vernerey, Magali Svrcek
Publikováno v:
Journal of Clinical Oncology. 37:3519-3519
3519 Background: Tumor deposits (TDs) are isolated tumor foci in the pericolic, perirectal or mesocolic fat without residual lymph node (LN) tissue. TDs seem to impact the prognosis of stage III colon cancer (CC) patients (pts) but are only considere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06f526b565e2d280a3f5b243eac290f6
https://doi.org/10.1200/jco.2019.37.15_suppl.3519
https://doi.org/10.1200/jco.2019.37.15_suppl.3519
Autor:
Jean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, Isabelle Martel-Lafay, Christophe Hennequin, Pierre-Luc Etienne, Véronique Vendrely, Eric François, Guy de La Roche, Olivier Bouché, Xavier Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Yves Bécouarn, Olivier Dupuis, Gérard Lledo, Jean-François Seitz, Laurent Bedenne, Béata Juzyna, Thierry Conroy
Publikováno v:
Journal of Clinical Oncology. 30:4558-4565
Purpose The ACCORD 12 trial investigated the value of two different preoperative chemoradiotherapy (CT-RT) regimens in T3-4 Nx M0 resectable rectal cancer. Clinical results are reported after follow-up of 3 years. Patients and Methods Between Novembe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888c20f662f302dc942a64c1524ebd8b
https://doi.org/10.1200/jco.2012.42.8771
https://doi.org/10.1200/jco.2012.42.8771
Autor:
Jean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, Isabelle Martel-Laffay, Christophe Hennequin, Pierre-Luc Etienne, Véronique Vendrely, Eric François, Guy de La Roche, Olivier Bouché, Xavier Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc André Mahé, Yves Bécouarn, Olivier Dupuis, Gérard Lledo, Christine Montoto-Grillot, Thierry Conroy
Publikováno v:
Journal of Clinical Oncology. 28:1638-1644
Purpose Neoadjuvant chemoradiotherapy is considered a standard approach for T3-4 M0 rectal cancer. In this situation, we compared neoadjuvant radiotherapy plus capecitabine with dose-intensified radiotherapy plus capecitabine and oxaliplatin. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0faf8993d944c63beb7cb52e2e7a98a7
https://doi.org/10.1200/jco.2009.25.8376
https://doi.org/10.1200/jco.2009.25.8376